Sanchez-Madrid F, Krensky A M, Ware C F, Robbins E, Strominger J L, Burakoff S J, Springer T A
Proc Natl Acad Sci U S A. 1982 Dec;79(23):7489-93. doi: 10.1073/pnas.79.23.7489.
Monoclonal antibodies were prepared to anti-HLA-DR cytolytic T lymphocytes (CTLs) and screened for inhibition of CTL-mediated killing. Binding of monoclonal antibodies to four types of molecules, LFA-1, LFA-2, LFA-3, and HLA-DR, inhibited killing, suggesting that these molecules participate in the CTL-target cell interaction. The antigens were characterized by immunoprecipitation, crosslinking, NaDodSO4/polyacrylamide gel electrophoresis, and immunofluorescence flow cytometry. The LFA-1 antigen contains alpha and beta polypeptide chains of Mr 177,000 and 95,000 that are noncovalently associated in an alpha 1 beta 1 structure. It is present on both B and T lymphocytes and marks subpopulations that differ in quantitative expression. Human LFA-1 appears to be the homologue of mouse LFA-1. Human LFA-2 is of Mr 49,000 with a minor component of Mr 36,000. It is expressed on CTL lines but not on a B-cell line and in peripheral blood preferentially on T lymphocytes. Human LFA-3 is of Mr 60,000 and is expressed on both B and T lymphocytes.
制备了针对抗 HLA - DR 细胞毒性 T 淋巴细胞(CTL)的单克隆抗体,并筛选其对 CTL 介导杀伤作用的抑制情况。单克隆抗体与四种分子(淋巴细胞功能相关抗原 -1(LFA -1)、淋巴细胞功能相关抗原 -2(LFA -2)、淋巴细胞功能相关抗原 -3(LFA -3)和 HLA - DR)的结合抑制了杀伤作用,这表明这些分子参与了 CTL 与靶细胞的相互作用。通过免疫沉淀、交联、十二烷基硫酸钠/聚丙烯酰胺凝胶电泳和免疫荧光流式细胞术对这些抗原进行了表征。LFA -1 抗原包含分子量为 177,000 和 95,000 的α和β多肽链,它们以α1β1 结构非共价结合。它存在于 B 淋巴细胞和 T 淋巴细胞上,并标记出在定量表达上不同的亚群。人 LFA -1 似乎是小鼠 LFA -1 的同源物。人 LFA -2 的分子量为 49,000,还有一个分子量为 36,000 的次要成分。它在 CTL 系上表达,但不在 B 细胞系上表达,在外周血中优先在 T 淋巴细胞上表达。人 LFA -3 的分子量为 60,000,在 B 淋巴细胞和 T 淋巴细胞上均有表达。